Suchergebnisse

Significantly, though, the book breaks with both traditional and current ways of thinking about war art-offering a radical rethinking of the politics and aesthetics of art today through analyses of a diverse scope of contemporary art that .

A qualitative methodology was used to research family resilience in families who have a child aged 0 - 8 years with disability. The research was conducted in two parts – a literature review and primary data collection with families (where a child 0 - 8 years of age has a disability) and other key stakeholders, such as service providers, family advocacy groups and government officials This report summarises the findings of the final report, which focuses on the findings from the primary data collection with families and stakeholders. It develops the understanding of family resilience in families with young children (0 - 8 years of age) with disability. This component of the research also analyses service practices and models in order to identify and define elements of practice that build family resilience, detract from family resiliency, and are crucial to the maintenance of resiliency. It concludes with a section on how services can assist families to build and maintain resilience. This report should be read in conjunction with the literature review.

AbstractThe amount of distress and disengagement among many nurses and physicians has reached concerning levels in recent years. The result has been acute nurse shortages, significant increases in travel nursing, more physicians working fewer hours and retiring early, and urgent calls for change and reform. This analysis surveys many of the leading systemic contributors to nurse and physician demoralization. As the healthcare sector continues to experience more consolidation and increased investment by private equity and other corporate interests, physicians are increasingly becoming employees with similar forms of employment arrangements and pressures that nurses have had for decades. They are also becoming employees of the same larger health systems, hospitals, and corporate employers. These trends are leading to a convergence in the kind and intensity of pressures and problems that nurses and physicians face. As more medical residents and fellows increasingly turn to unionization and as growing numbers of nurses have gone on strike, both professions should consider the potential benefits of joining forces for the purposes of maintaining the autonomy they have left and to push for better conditions both for themselves and the patients for whom they care.

Without appropriate support, people with mental illness can be excluded from stable housing and social and community participation. Transitional models of support for people with acute mental illness have addressed clinical symptoms and hospitalisation, but they have not facilitated stable housing and community integration. In contrast, individualised housing models aim to improve mental health, housing and community outcomes. These programs are costly and require collaboration between agencies. This article discusses the evaluation findings of one such program – the NSW Mental Health Housing and Accommodation Support Initiative (HASI). The longitudinal mixed‐method evaluation assessed whether HASI supported people with high levels of psychiatric disability to improve housing, mental health and community participation. We discuss the challenges clients within the program faced prior to joining HASI and the changes experienced while in HASI. We conclude by drawing policy implications for programs supporting people with mental illness to live in the community.

Definitions of financial wellbeing have begun to emerge internationally [e.g., Consumer Finances Protection Bureau 7]. However, Australia lacks a definition. This project, commissioned by Financial Literacy Australia, fills this gap. It provides a definition for financial wellbeing that aims to be relevant to, and meaningful for, Australians of different ages and the people who work to improve financial outcomes. The project asked:- What is financial wellbeing, and what are its different parts?- What are the factors that influence financial wellbeing?- Where does financial capability fit in?- How can we measure financial wellbeing?These questions were answered using data from an international literature review; focus groups and interviews with 72 people; a survey of 821 people living in Australia aged 18 and over; and consultations with experts in the field (from for-profit, not-for-profit and government sectors).

The central dilemma facing Zimbabwe's new government is the need to find a balance between improving the farm sector & the lot of peasants & wage earners, while maintaining confidence in the commercial, industrial, & agricultural sectors. Focus is on new minimum wage legislation introduced in July 1980. The tobacco & maize industries, which represent Zimbabwe's major crops, are analyzed in detail. The disparity between wage labor & peasant farmers has increased, but a fall in employment & an increase in productivity, capital investment, & management efficiency are predicted, along the patterns exhibited by other developing nations. Annual income of some families of farm laborers is forecast to fall because of decreased demand for the seasonal labor of women & children. Caution in minimum wage legislation is suggested, & the preferability of pricing policy underscored. 1 Table. C. Ornatowski.

This report examines the formal social housing pathways set out in policy and how these differ across jurisdictions. It uses a systems thinking approach to examine how actors, levers, feedback loops, incentives and disincentives influence formal social housing pathways. The discussion presents evidence from a comprehensive policy review, as well as data from interviews and a workshop with key stakeholders, including government representatives and community housing managers.

headspace, the National Youth Mental Health Foundation is an Australian Government initiative first funded as part of the Federal Budget commitment to the Youth Mental Health Initiative (2005–06 to 2008–09), and launched in 2006. It aims to promote and facilitate improvements in the mental health, social wellbeing and economic participation of young Australians aged 12-25 years. This interim report is structured around the logic model of headspace to provide an understanding of how headspace works, the progress achieved thus far, and the factors that have facilitated and hindered establishment and implementation. For headspace to achieve its aims, it is critically important that headspace is delivering the required services, that young people are accessing these services, and that the services are appropriate and of quality. It is also important that headspace has started the process of establishing referral pathways beyond the Communities of Youth Services CYSs, and that it is having some impact on broader service reform.

headspace aims to improve the mental health and social and emotional wellbeing of young people in Australia through the provision of evidence-based, integrated, youth-centred and holistic services. In January 2013, the Australian Government Department of Health (DoH) commissioned a consortium of researchers from the Social Policy Research Centre and the Centre for Social Impact, UNSW Australia; Bankwest Curtin Economics Centre, Curtin University; and the Telethon Kids Institute, University of Western Australia to evaluate the effectiveness of headspace.The evaluation aimed to: examine young people's access to and engagement with the centre-based program; assess the outcomes of young people who have received services from headspace to determine the effectiveness of the treatment; assess the centre-based program's service delivery model; and to conduct a cost effectiveness analysis of the program. This report presents the evaluation findings.

headspace, the National Youth Mental Health Foundation, was launched in 2006 as part of the Australian Government's commitment to the Youth Mental Health Initiative (YMHI). It was established to promote and facilitate improvements in the mental health, social wellbeing and economic participation of young people aged 12-25-years-old. headspace aims to achieve this by: • Providing holistic services via Communities of Youth Services (CYSs); • Increasing community capacity to identify young people with mental ill-health and related problems as early as possible; • Encouraging help-seeking by young people and their carers; • Providing evidence-based, quality services delivered by well-trained professionals; and • Impacting on service reform in terms of service coordination and integration within communities and at an Australian and state/territory government level. In 2008, the Social Policy Research Centre (SPRC) was contracted by headspace and the University of Melbourne (UoM) to conduct the first independent evaluation of headspace. The evaluation is a longitudinal, mixed methods research project, established to examine the achievements, limitations and future directions of the headspace program. The evaluation draws on qualitative and quantitative data from primary and secondary sources collected over two waves.

The Australian Government Department of Families, Housing, Community Services and Indigenous Affairs (FaHCSIA) contracted the Social Policy Research Centre (SPRC), University of New South Wales (UNSW), and the Australian Institute of Family Studies (AIFS), to evaluate the Stronger Families and Communities Strategy (SFCS) 2004–2009. The evaluation ran from 2004–2008. The SFCS aimed to: -help families and communities build better futures for children -build family and community capacity -support relationships between families and the communities they live in -improve the ability of communities to help themselves. It contained four strands: Communities for Children (CfC), Invest to Grow (ItG), Local Answers (LA), and Choice and Flexibility in Child Care. The latter was not included in the evaluation. The national evaluation evaluated the first three strands (CfC, ItG and LA), with the main focus on CfC. This report presents the findings of the evaluation.

Conflict of interest statementAK reports grants from European Union 7th Framework Program during the conduct of the study. ADM has nothing to disclose. CM has nothing to disclose. AW has nothing to disclose. ES has nothing to disclose. ME reports grants from European Union 7th Framework Program during the conduct of the study. THC has nothing to disclose. MEn reports grants from European Union 7th Framework Program during the conduct of the study, grants from Bayer and fees paid to the Charité from Bayer, Boehringer Ingelheim, BMS/Pfizer, Daiichi Sankyo, Amgen, GlaxoSmithKlineGSK, Sanofi, Covidien, Novartis, all outside the submitted work. JBF reports grants from European Union 7th Framework Program during the conduct of the study and personal fees from Bioclinica, BMS, Biogen, Artemida, Cerevast, Guerbet, EISAI and Nicolab outside the submitted work. JF has nothing to disclose. IG reports grants from European Union 7th Framework Program during the conduct of the study. JP has nothing to disclose. VT reports grants from European Union 7th Framework Program and personal fees and non-financial support from Boehringer Ingelheim, Pfizer/BMS, Bayer, Sygnis, Amgen and Allergan outside the submitted work. RL reports no personal fees, but institutional support for consultancy and speaker fees from Bayer, Boehringer-Ingelheim, Genentech, Ischemaview, Medtronic and Occlutech outside the submitted work. KWM reports grants from European Union 7th Framework Program during the conduct of the study, personal fees and non-financial support from Boehringer Ingelheim outside the submitted work, personal fees from Boehringer Ingelheim, Bayer, Daiichi Sankyo and ReNeuron outside the submitted work. NN has nothing to disclose. SP reports grants from European Union 7th Framework Program during the conduct of the study. CZS reports grants from Novo Nordisk Foundation and personal fees from Bayer outside the submitted work. CG reports grants from European Union 7th Framework Program during the conduct of the study, personal fees from AMGEN, Bayer Vital, BMS, Boehringer Ingelheim, Sanofi Aventis, Abbott, and Prediction Biosciences outside the submitted work. GT reports grants from European Union 7th Framework Program during the conduct of the study, personal fees from Acandis, Boehringer Ingelheim, BMS/Pfizer, Stryker, Daiichi Sankyo, grants and personal fees from Bayer, grants from Corona Foundation, German Innovation Fonds and Else Kroener Fresenius Foundation outside the submitted work. BC reports grants from European Union 7th Framework Program during the conduct of the study and personal fees from Bayer Vital and Abbott, all outside the submitted work. ; International audience ; Stroke has a deleterious impact on quality of life. However, it is less well known if stroke lesions in different brain regions are associated with reduced quality of life (QoL). We therefore investigated this association by multivariate lesion-symptom mapping. We analyzed magnetic resonance imaging and clinical data from the WAKE-UP trial. European Quality of Life 5 Dimensions (EQ-5D) 3 level questionnaires were completed 90 days after stroke. Lesion symptom mapping was performed using a multivariate machine learning algorithm (support vector regression) based on stroke lesions 22-36 h after stroke. Brain regions with significant associations were explored in reference to white matter tracts. Of 503 randomized patients, 329 were included in the analysis (mean age 65.4 years, SD 11.5; median NIHSS = 6, IQR 4-9; median EQ-5D score 90 days after stroke 1, IQR 0-4, median lesion volume 3.3 ml, IQR 1.1-16.9 ml). After controlling for lesion volume, significant associations between lesions and EQ-5D score were detected for the right putamen, and internal capsules of both hemispheres. Multivariate lesion inference analysis revealed an association between injuries of the cortico-spinal tracts with worse self-reported quality of life 90 days after stroke in comparably small stroke lesions, extending previous reports of the association of striato-capsular lesions with worse functional outcome. Our findings are of value to identify patients at risk of impaired QoL after stroke.

Conflict of interest statementAK reports grants from European Union 7th Framework Program during the conduct of the study. ADM has nothing to disclose. CM has nothing to disclose. AW has nothing to disclose. ES has nothing to disclose. ME reports grants from European Union 7th Framework Program during the conduct of the study. THC has nothing to disclose. MEn reports grants from European Union 7th Framework Program during the conduct of the study, grants from Bayer and fees paid to the Charité from Bayer, Boehringer Ingelheim, BMS/Pfizer, Daiichi Sankyo, Amgen, GlaxoSmithKlineGSK, Sanofi, Covidien, Novartis, all outside the submitted work. JBF reports grants from European Union 7th Framework Program during the conduct of the study and personal fees from Bioclinica, BMS, Biogen, Artemida, Cerevast, Guerbet, EISAI and Nicolab outside the submitted work. JF has nothing to disclose. IG reports grants from European Union 7th Framework Program during the conduct of the study. JP has nothing to disclose. VT reports grants from European Union 7th Framework Program and personal fees and non-financial support from Boehringer Ingelheim, Pfizer/BMS, Bayer, Sygnis, Amgen and Allergan outside the submitted work. RL reports no personal fees, but institutional support for consultancy and speaker fees from Bayer, Boehringer-Ingelheim, Genentech, Ischemaview, Medtronic and Occlutech outside the submitted work. KWM reports grants from European Union 7th Framework Program during the conduct of the study, personal fees and non-financial support from Boehringer Ingelheim outside the submitted work, personal fees from Boehringer Ingelheim, Bayer, Daiichi Sankyo and ReNeuron outside the submitted work. NN has nothing to disclose. SP reports grants from European Union 7th Framework Program during the conduct of the study. CZS reports grants from Novo Nordisk Foundation and personal fees from Bayer outside the submitted work. CG reports grants from European Union 7th Framework Program during the conduct of the study, personal fees from AMGEN, Bayer Vital, BMS, Boehringer Ingelheim, Sanofi Aventis, Abbott, and Prediction Biosciences outside the submitted work. GT reports grants from European Union 7th Framework Program during the conduct of the study, personal fees from Acandis, Boehringer Ingelheim, BMS/Pfizer, Stryker, Daiichi Sankyo, grants and personal fees from Bayer, grants from Corona Foundation, German Innovation Fonds and Else Kroener Fresenius Foundation outside the submitted work. BC reports grants from European Union 7th Framework Program during the conduct of the study and personal fees from Bayer Vital and Abbott, all outside the submitted work. ; International audience ; Stroke has a deleterious impact on quality of life. However, it is less well known if stroke lesions in different brain regions are associated with reduced quality of life (QoL). We therefore investigated this association by multivariate lesion-symptom mapping. We analyzed magnetic resonance imaging and clinical data from the WAKE-UP trial. European Quality of Life 5 Dimensions (EQ-5D) 3 level questionnaires were completed 90 days after stroke. Lesion symptom mapping was performed using a multivariate machine learning algorithm (support vector regression) based on stroke lesions 22-36 h after stroke. Brain regions with significant associations were explored in reference to white matter tracts. Of 503 randomized patients, 329 were included in the analysis (mean age 65.4 years, SD 11.5; median NIHSS = 6, IQR 4-9; median EQ-5D score 90 days after stroke 1, IQR 0-4, median lesion volume 3.3 ml, IQR 1.1-16.9 ml). After controlling for lesion volume, significant associations between lesions and EQ-5D score were detected for the right putamen, and internal capsules of both hemispheres. Multivariate lesion inference analysis revealed an association between injuries of the cortico-spinal tracts with worse self-reported quality of life 90 days after stroke in comparably small stroke lesions, extending previous reports of the association of striato-capsular lesions with worse functional outcome. Our findings are of value to identify patients at risk of impaired QoL after stroke.

Conflict of interest statementAK reports grants from European Union 7th Framework Program during the conduct of the study. ADM has nothing to disclose. CM has nothing to disclose. AW has nothing to disclose. ES has nothing to disclose. ME reports grants from European Union 7th Framework Program during the conduct of the study. THC has nothing to disclose. MEn reports grants from European Union 7th Framework Program during the conduct of the study, grants from Bayer and fees paid to the Charité from Bayer, Boehringer Ingelheim, BMS/Pfizer, Daiichi Sankyo, Amgen, GlaxoSmithKlineGSK, Sanofi, Covidien, Novartis, all outside the submitted work. JBF reports grants from European Union 7th Framework Program during the conduct of the study and personal fees from Bioclinica, BMS, Biogen, Artemida, Cerevast, Guerbet, EISAI and Nicolab outside the submitted work. JF has nothing to disclose. IG reports grants from European Union 7th Framework Program during the conduct of the study. JP has nothing to disclose. VT reports grants from European Union 7th Framework Program and personal fees and non-financial support from Boehringer Ingelheim, Pfizer/BMS, Bayer, Sygnis, Amgen and Allergan outside the submitted work. RL reports no personal fees, but institutional support for consultancy and speaker fees from Bayer, Boehringer-Ingelheim, Genentech, Ischemaview, Medtronic and Occlutech outside the submitted work. KWM reports grants from European Union 7th Framework Program during the conduct of the study, personal fees and non-financial support from Boehringer Ingelheim outside the submitted work, personal fees from Boehringer Ingelheim, Bayer, Daiichi Sankyo and ReNeuron outside the submitted work. NN has nothing to disclose. SP reports grants from European Union 7th Framework Program during the conduct of the study. CZS reports grants from Novo Nordisk Foundation and personal fees from Bayer outside the submitted work. CG reports grants from European Union 7th Framework Program during the conduct of the study, personal fees from ...